MyoKardia (MYOK) sees Significant Insider Selling Continuing

Wednesday, October 04, 2017 10:15 PM ET

MyoKardia (MYOK) sees Significant Insider Selling Continuing

A SEC filing today disclosed a notable insider sale of MyoKardia shares as — Kevin P Starr, 10% Owner and Director — sold 75,313 shares in the company having a market value of approximately $3,033,578. There have been 6 insiders with buy/sell transactions in the past 90 days prior to this filing. These trades have resulted in the acquisition of 351,408 company shares and the sale of 1,669,633 company shares over this time period. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 1,393,538 shares and have averaged 299,479 shares per transaction over this time period.

Compared to its peers over the last 90 days, insider buy/sell trading at MyoKardia is higher than the 264-company peer group average. Bio Therapeutic Drugs peer group saw 316 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for MyoKardia insiders was also higher. Within the peer group there were 10,004,233 shares purchased and 20,610,506 shares sold with company insiders disposing of 33,564 shares on average.

In order to focus on significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated data obtained to evaluate and write this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.